Article Text

Download PDFPDF
Best Practice No 181
  1. T M Reynolds
  1. Correspondence to:
 Professor T M Reynolds
 Clinical Chemistry Department, Queen’s Hospital, Belvedere Road, Burton on Trent, Staffordshire DE13 0RB, UK; tim.reynoldsburtonh-tr.wmids.nhs.uk

Chemical pathology clinical investigation and management of nephrolithiasis

Abstract

Renal stones have afflicted humans for millennia but there is still no solution to this problem. This review discusses the laboratory and metabolic aspects of the clinical management of patients with renal stones, both primary and secondary in origin. First, non-pharmacological interventions such as increased fluid intake, decreased protein consumption, dietary changes in sodium, calcium, oxalate, potassium, purine, vitamins, and essential fatty acids are considered. Then specific pharmacological treatment to modify urine calcium, oxalate, urate, citrate, and acidity are considered. Finally, more unusual types of stone are examined.

  • nephrolithiasis
  • calcium oxalate
  • clinical management
  • cystinuria
  • uric acid

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Chemical pathology clinical investigation and management of nephrolithiasis

View Full Text

Footnotes